BMS-986172   Click here for help

GtoPdb Ligand ID: 12971

Synonyms: BMS986172 | compound 12 [PMID: 37724542]
Compound class: Synthetic organic
Comment: BMS-986172 acts as a monoacylglycerol O-acyltransferase 2 (MGAT2) inhibitor [1]. MGAT2 inhibitors are candidates for the treatment of diabetes, obesity and associated metabolic disorders.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 10
Hydrogen bond donors 2
Rotatable bonds 11
Topological polar surface area 110.99
Molecular weight 589.47
XLogP 2.99
No. Lipinski's rules broken 2
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C(CC(F)(F)F)COC1=CC=C(C(=C1)F)[C@@]2(CC(=C(C(=O)N2)N3C(=O)NN=N3)C4=NN(C=C4)CC5CC5)C(F)(F)F
Isomeric SMILES FC1=C(C=CC(OCCCC(F)(F)F)=C1)[C@@]2(CC(C3=NN(CC4CC4)C=C3)=C(N5N=NNC5=O)C(=O)N2)C(F)(F)F
InChI InChI=1S/C24H22F7N7O3/c25-17-10-14(41-9-1-7-23(26,27)28)4-5-16(17)22(24(29,30)31)11-15(18-6-8-37(34-18)12-13-2-3-13)19(20(39)32-22)38-21(40)33-35-36-38/h4-6,8,10,13H,1-3,7,9,11-12H2,(H,32,39)(H,33,36,40)/t22-/m0/s1
InChI Key VFFPVFKSCNJAMO-QFIPXVFZSA-N
No information available.
Summary of Clinical Use Click here for help
BMS-986172 is an early stage clinical lead for the treatment of obesity.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT04926051 A Study to Assess the Safety, Tolerability and Drug Levels of BMS-986172 in Healthy and Obese Participants, Including an Assessment of the Effects of Food on BMS-986172 Absorption Phase 1 Interventional Bristol-Myers Squibb